Skip to content

APOTHEEK DE SCHELDE: what changed

What changed

APOTHEEK DE SCHELDE

BE 0870.957.852
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Financial years compared with
Net result for the year
€27,643
2024 · -€137,088+€164,731
Equity
€86,585
2024 · €58,942+€27,643
Cash
€36,913
2024 · €3,801+€33,112
Balance sheet total
€242,393
2024 · €674,450-€432,057

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets -€474,679

    down €474,679 (-100%), from €474,679 to €0

  • Cash +€33,112

    up €33,112 (+871%), from €3,801 to €36,913

    mainly Investment in fixed assets (net) (+€474,679) and Net result for the year (+€27,643)

  • Receivables within one year +€12,227

    up €12,227 (+6.7%), from €182,763 to €194,990

    of which Other amounts receivable: +€12,227

Equity and liabilities
  • Debts after one year -€390,206

    down €390,206 (-100%), from €390,206 to €0

  • Current portion of long-term debt -€71,738

    down €71,738 (-100%), from €71,738 to €0

  • Profit (loss) carried forward +€27,643

    up €27,643 (+20.0%), from -€137,920 to -€110,277

Income statement
  • Gross operating margin +€124,609

    up €124,609, from -€90,110 to €34,499

  • Depreciation -€22,860

    down €22,860 (-100%), from €22,860 to €0

  • Financial charges -€20,701

    down €20,701 (-60.3%), from €34,338 to €13,637

  • Financial income -€2,717

    down €2,717 (-20.6%), from €13,207 to €10,490

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€137,088
Gross operating margin +€124,609
Depreciation +€22,860
Other operating charges -€722
Financial income -€2,717
Financial charges +€20,701
Result 2025 €27,643
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€20,377
Investment +€474,679
Financing -€461,944
Cash 2024 €3,801
Net result for the year +€27,643
Receivables within one year -€12,227
Deferred charges and accrued income +€2,717
Smaller working-capital items +€463
Other debts +€1,781
Investment in fixed assets (net) +€474,679
Debts after one year -€390,206
Current portion of long-term debt -€71,738
Cash 2025 €36,913
brings cash intakes cash out
Every line side by side 43 lines
Line Code 2024 2025 Change %
Total assets 20/58 €674,450 €242,393 -€432,057 -64.1%
Fixed assets 21/28 €474,679 €0 -€474,679 -100%
Tangible fixed assets 22/27 €474,679 €0 -€474,679 -100%
Land and buildings 22 €474,679 €0 -€474,679 -100%
Current assets 29/58 €199,771 €242,393 +€42,622 +21.3%
Stocks and contracts in progress 3 €0 - =
Stocks 30/36 €0 - =
Amounts receivable within one year 40/41 €182,763 €194,990 +€12,227 +6.7%
Trade receivables 40 €0 - =
Other amounts receivable 41 €182,763 €194,990 +€12,227 +6.7%
Cash at bank and in hand 54/58 €3,801 €36,913 +€33,112 +871%
Deferred charges and accrued income 490/1 €13,207 €10,490 -€2,717 -20.6%
Total equity and liabilities 10/49 €674,450 €242,393 -€432,057 -64.1%
Equity 10/15 €58,942 €86,585 +€27,643 +46.9%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €178,262 €178,262 = 0.0%
Non-distributable reserves 130/1 €1,860 €1,860 = 0.0%
Reserves not available under the articles 1311 €1,860 €1,860 = 0.0%
Distributable reserves 133 €176,402 €176,402 = 0.0%
Profit (loss) carried forward 14 -€137,920 -€110,277 +€27,643 +20.0%
Amounts payable 17/49 €615,509 €155,808 -€459,701 -74.7%
Amounts payable after more than one year 17 €390,206 €0 -€390,206 -100%
Financial debts 170/4 €390,206 €0 -€390,206 -100%
Amounts payable within one year 42/48 €225,303 €155,808 -€69,495 -30.8%
Current portion of amounts payable after more than one year 42 €71,738 €0 -€71,738 -100%
Trade debts 44 €57 €33 -€24 -41.4%
Suppliers 440/4 €57 €33 -€24 -41.4%
Taxes, remuneration and social security 45 €0 €487 +€487
Taxes 450/3 €0 €487 +€487
Other amounts payable 47/48 €153,508 €155,288 +€1,781 +1.2%
Accrued charges and deferred income 492/3 €0 - =
Non-recurring operating income 76A - €30,221 +€30,221
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €22,860 €0 -€22,860 -100%
Other operating charges 640/8 €2,987 €3,709 +€722 +24.2%
Gross operating margin 9900 -€90,110 €34,499 +€124,609
Operating profit (loss) 9901 -€115,957 €30,790 +€146,747
Financial income 75/76B €13,207 €10,490 -€2,717 -20.6%
Recurring financial income 75 €13,207 €10,490 -€2,717 -20.6%
Financial charges 65/66B €34,338 €13,637 -€20,701 -60.3%
Recurring financial charges 65 €34,338 €13,637 -€20,701 -60.3%
Profit (loss) for the period before taxes 9903 -€137,088 €27,643 +€164,731
Profit (loss) for the period 9904 -€137,088 €27,643 +€164,731
Profit (loss) for the period to be appropriated 9905 -€137,088 €27,643 +€164,731
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 7 November 2026 via checked.be.